AdvaMedDx

CMS gave labs an additional year to gear up for the implementation of the Protecting Access to Medicare Act of 2014 and clarified key programmatic definitions.

Multiple legislative proposals before Congress show regulation of lab-developed tests remains divisive within the life sciences community.

Kapa Biosystems said this week that it has added four new managers as part of the company's expansion, which included moving and in

AdvaMedDx announced this week that it has elected John Bishop, CEO of Cepheid, as the new chair of its board of directors. Before joining Cepheid in 2002, he was CEO and president of Vysis.

This article has been updated with information about a Citizen Petition filed against FDA regulation of LDTs by the American Clinical Laboratory Association, and with quotes from Sherri Bale. Originally published June 4.

AdvaMedDx, a division of the Advanced Medical Technology Association, announced the election of several new members to its board of directors.

Originally published Oct. 1.
A new bill strongly supported within the diagnostics industry could put pressure on the Centers for Medicare & Medicaid Services to alter its procedures for setting reimbursement rates for molecular diagnostics.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.